A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice
Molecular Therapy: Methods & Clinical Development, 32(2), 101269
Publications
Molecular Therapy: Methods & Clinical Development, 32(2), 101269